XTL BIOPHARMACEUTICALS LTD reports

Company location
New York, NY
XTL BIOPHARMACEUTICALS LTD has filed 546 SEC EDGAR filings since 17 Nov 2004

SEC filing history

Showing 1-21 of 21 matching filings.

Per page
25
Current page
1
20-F File 001-36000

ANNUAL REPORT

Filing date
30 Jun 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
20-F File 001-36000

ANNUAL REPORT

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
20-F File 001-36000

ANNUAL REPORT

Filing date
30 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
20-F File 001-36000

ANNUAL REPORT

Filing date
22 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
20-F File 001-36000

ANNUAL REPORT

Filing date
30 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
20-F/A File 001-36000

AMENDMENT NO. 1 TO FORM 20-F

Filing date
19 May 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
20-F File 001-36000

ANNUAL REPORT

Filing date
15 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
20-F File 001-36000

ANNUAL REPORT

Filing date
12 Mar 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
20-F File 001-36000

ANNUAL REPORT

Filing date
11 Mar 2019
Reporting date
31 Dec 2018
Next action
Verify source filing
20-F File 001-36000

ANNUAL REPORT

Filing date
15 Mar 2018
Reporting date
31 Dec 2017
Next action
Verify source filing
20-F/A File 001-36000

20-F/A

Filing date
03 Apr 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 001-36000

FORM 20-F

Filing date
30 Mar 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 001-36000

20-F

Filing date
31 Mar 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 001-36000

FORM 20-F

Filing date
28 Apr 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 001-36000

FORM 20-F

Filing date
02 Apr 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 000-51310

FORM 20-F

Filing date
25 Apr 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F/A File 000-51310

AMENDMENT NO. 2

Filing date
11 Jun 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F/A File 000-51310

FORM 20-F/A

Filing date
30 Mar 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 000-51310

FORM 20-F

Filing date
29 Mar 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 000-51310

ANNUAL REPORT

Filing date
31 May 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 000-51310

20-F filing

Filing date
30 Jun 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .